Valerie Jensen, the Associate Director of the Drug Shortages staff in FDA's Center for Drug Evaluation and Research, joins Dr. Shah for a discussion on drug shortages and how the COVID-19 pandemic can impact the drug supply chain.

The Opioid Epidemic and COVID-19 Pandemic

Join Dr. Anand Shah, FDA's Deputy Commissioner for Medical and Scientific Affairs, and other FDA leaders as they provide their insight into issues facing the agency, including the COVID-19 pandemic and other emerging topics.